טוען...
Familial Hypercholesterolemia and Lipoprotein Apheresis
Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is the main pathogenic factor. Currently, three procedures are available in Japan, including the plasma exchange, double-membrane filtration, and...
שמור ב:
| הוצא לאור ב: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Japan Atherosclerosis Society
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711846/ https://ncbi.nlm.nih.gov/pubmed/31231083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17033 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|